{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:47:49Z","timestamp":1793407669542,"version":"4.5.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01087","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T04:13:40Z","timestamp":1571112820000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Sebastiaan P.","family":"van Kessel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"El Aidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"Feigin","year":"2017","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson's disease in the United States","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/mds.20279","article-title":"Impact of the motor complications of Parkinson's disease on the quality of life","volume":"20","author":"Chapuis","year":"2005","journal-title":"Mov Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease","volume":"26","author":"Martinez-Martin","year":"2011","journal-title":"Mov Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","article-title":"Alteration of the fecal microbiota in Chinese patients with Parkinson's disease","volume":"70","author":"Qian","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson's disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"eaar5280","DOI":"10.1126\/scitranslmed.aar5280","article-title":"The vermiform appendix impacts the risk of developing Parkinson's disease","volume":"10","author":"Killinger","year":"2018","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1211\/jpp\/61.10.0005","article-title":"In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?","volume":"61","author":"Niehues","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1212\/01.wnl.0000221672.01272.ba","article-title":"Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations","volume":"66","author":"Pierantozzi","year":"2006","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1212\/WNL.50.3_Suppl_3.S1","article-title":"An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines","volume":"50","author":"Olanow","year":"1998","journal-title":"Am Acad Neurol Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1212\/WNL.56.suppl_5.S1","article-title":"An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines","volume":"56","author":"Olanow","year":"2001","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","article-title":"Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study","volume":"13","author":"Olanow","year":"2014","journal-title":"Lancet Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s40262-017-0511-y","article-title":"Pharmacokinetics of Rytary\u00ae, an extended-release capsule formulation of carbidopa\u2013levodopa","volume":"56","author":"Mittur","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"B26","first-page":"335","article-title":"Continuous levodopa for advanced Parkinson's disease","volume":"3","author":"Lundqvist","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/brain\/107.2.487","article-title":"On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study","volume":"107","author":"Hardie","year":"1984","journal-title":"Brain"},{"key":"B28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1212\/01.WNL.0000149637.70961.4C","article-title":"Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease","volume":"64","author":"Nyholm","year":"2005","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00544017","article-title":"Intestinal absorption of levodopa in man","volume":"25","author":"Gundert-Remy","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1124\/jpet.114.216317","article-title":"The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease","volume":"351","author":"Camargo","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1152\/physrev.00018.2006","article-title":"Amino acid transport across mammalian intestinal and renal epithelia","volume":"88","author":"Br\u00f6er","year":"2008","journal-title":"Physiol Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/clpt.2013.175","article-title":"Profiling solute carrier transporters in the human blood-brain barrier","volume":"94","author":"Geier","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1471-4159.1975.tb04415.x","article-title":"Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier","volume":"25","author":"Wade","year":"1975","journal-title":"J Neurochem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","article-title":"The 4F2hc\/LAT1 complex transports L-DOPA across the blood-brain barrier","volume":"879","author":"Kageyama","year":"2000","journal-title":"Brain Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jn\/132.4.733","article-title":"L-type amino acid transporters in two intestinal epithelial cell lines function as exchangers with neutral amino acids","volume":"132","author":"Fraga","year":"2002","journal-title":"J Nutr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1365-201X.2002.00974.x","article-title":"Regulation of apical transporter of L-DOPA in human intestinal Caco-2 cells","volume":"175","author":"Fraga","year":"2002","journal-title":"Acta Physiol Scand"},{"key":"B37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0014-2999(02)01416-4","article-title":"The L-3,4-dihydroxyphenylalanine transporter in human and rat epithelial intestinal cells is a type 2 hetero amino acid exchanger","volume":"441","author":"Fraga","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00726-005-0221-x","article-title":"Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cells","volume":"29","author":"Fraga","year":"2005","journal-title":"Amino Acids"},{"key":"B39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1523-1755.2004.00722.x","article-title":"Over-expression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells","volume":"66","author":"Pinho","year":"2004","journal-title":"Kidney Int"},{"key":"B40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00232-001-0136-8","article-title":"Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines","volume":"186","author":"Gomes","year":"2002","journal-title":"J Membr Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-60761-700-6_16","article-title":"Xenopus laevis Oocytes","volume":"637","author":"Br\u00f6er","year":"2010","journal-title":"Methods Mol Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1124\/mol.61.4.729","article-title":"Transport of amino acid-related compounds mediated by L-type Amino Acid Transporter 1 (LAT1): insights into the mechanisms of substrate recognition","volume":"61","author":"Uchino","year":"2002","journal-title":"Mol Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"F74","DOI":"10.1152\/ajprenal.00237.2003","article-title":"The dopamine precursor l -dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex","volume":"287","author":"Qui\u00f1ones","year":"2004","journal-title":"Am J Physiol Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0005-2736(00)00171-1","article-title":"Involvement of rBAT in Na+-dependent and -independent transport of the neurotransmitter candidate L-DOPA in Xenopus laevis oocytes injected with rabbit small intestinal epithelium poly A+ RNA","volume":"1466","author":"Ishii","year":"2000","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"B45","doi-asserted-by":"publisher","first-page":"17221","DOI":"10.1074\/jbc.M009462200","article-title":"Expression cloning of a Na + -independent aromatic amino acid transporter with structural similarity to H + \/Monocarboxylate transporters","volume":"276","author":"Kim","year":"2001","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.parkreldis.2005.01.009","article-title":"Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson","volume":"11","author":"Kim","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"B47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/cpt1972134584","article-title":"Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2-14C-dopa","volume":"13","author":"Bianchine","year":"1972","journal-title":"Clin Pharmacol Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archneur.1971.00490010049007","article-title":"Metabolism of levodopa in patients with Parkinson's disease","volume":"25","author":"Morgan","year":"1971","journal-title":"Arch Neurol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jps.2600700705","article-title":"Dosage form design for improvement of bioavailability of levodopa IV: possible causes of low bioavailability of oral levodopa in dogs","volume":"70","author":"Sasahara","year":"1981","journal-title":"J Pharm Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.2042-7158.1987.tb03413.x","article-title":"Effect of age on gastrointestinal and hepatic first-pass effects of levodopa in rats","volume":"39","author":"Iwamoto","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2125.1989.tb03506.x","article-title":"The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa","volume":"28","author":"Robertson","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/BF00626370","article-title":"Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease","volume":"41","author":"Contin","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.parkreldis.2010.11.002","article-title":"Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson's disease","volume":"17","author":"Nagayama","year":"2011","journal-title":"Park Relat Disord"},{"key":"B54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0140-6736(76)90194-X","article-title":"Letter: do changes in blood levels of other aromatic aminoacids influence levodopa therapy?","volume":"1","author":"Daniel","year":"1976","journal-title":"Lancet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1056\/NEJM198402233100802","article-title":"The on\u2013off phenomenon in Parkinson's disease","volume":"310","author":"Nutt","year":"1984","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1136\/jnnp.52.9.1063","article-title":"The effects of oral protein on the absorption of intraduodenal levodopa and motor performance","volume":"52","author":"Frankel","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jnnp.52.4.481","article-title":"Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa","volume":"52","author":"Nutt","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B58","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.410200212","article-title":"Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography","volume":"20","author":"Leenders","year":"1986","journal-title":"Ann Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2125.1993.tb05691.x","article-title":"The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man","volume":"35","author":"Lennernas","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/mds.23226","article-title":"Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review","volume":"25","author":"Cereda","year":"2010","journal-title":"Mov Disord"},{"key":"B61","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/npjsba.2016.13","article-title":"Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients","volume":"2","author":"Guebila","year":"2016","journal-title":"Npj Syst Biol Appl"},{"key":"B62","first-page":"160","article-title":"Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat","volume":"186","author":"Goldin","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/229414a0","article-title":"Therapeutic implications in Parkinsonism of m-tyramine formation from L-dopa in man","volume":"229","author":"Sandler","year":"1971","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.gastro.2005.11.046","article-title":"Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics","volume":"130","author":"Quigley","year":"2006","journal-title":"Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.23566","article-title":"Prevalence of small intestinal bacterial overgrowth in Parkinson's disease","volume":"26","author":"Gabrielli","year":"2011","journal-title":"Mov Disord"},{"key":"B66","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","article-title":"Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial","volume":"149","author":"Freedberg","year":"2015","journal-title":"Gastroenterology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"B69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/gut.35.1.23","article-title":"Duodenal bacterial overgrowth during treatment in outpatients with omeprazole","volume":"35","author":"Fried","year":"1994","journal-title":"Gut"},{"key":"B70","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1111\/j.1708-8305.2001.tb00545.x","article-title":"Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea","volume":"8","author":"Steffen","year":"2001","journal-title":"J Travel Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson's disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov Disord"},{"key":"B72","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ana.1267","article-title":"Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients","volume":"50","author":"Pierantozzi","year":"2001","journal-title":"Ann Neurol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s100720170061","article-title":"Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients","volume":"22","author":"Pierantozzi","year":"2001","journal-title":"Neurol Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/WNF.0000000000000037","article-title":"Pharmacokinetics of levodopa in patients with parkinson disease and motor fluctuations depending on the presence of helicobacter pylori infection","volume":"37","author":"Narozanska","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mds.22190","article-title":"Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease","volume":"23","author":"Lee","year":"2008","journal-title":"Mov Disord"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1007\/s00415-013-7089-6","article-title":"Motor fluctuations and Helicobacter pylori in Parkinson's disease","volume":"260","author":"Rahne","year":"2013","journal-title":"J Neurol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2036.2008.03906.x","article-title":"Systematic review: heliocobacter pylori infection and impaired drug absorption","volume":"29","author":"Lahner","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"B78","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/gut.23.1.66","article-title":"Effect of metoclopramide in guinea-pig ileum longitudinal muscle: evidence against dopamine-mediation","volume":"23","author":"Zar","year":"1982","journal-title":"Gut"},{"key":"B79","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF00501170","article-title":"The inhibition by dopamine of cholinergic transmission in the isolated guinea-pig ileum. Mediation through alpha-adrenoceptors Naunyn Schmiedebergs","volume":"318","author":"G\u00f6rich","year":"1982","journal-title":"Arch Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/1043-6618(90)90750-8","article-title":"Dopamine-induced relaxation of the guinea-pig isolated jejunum is not mediated through dopamine receptors","volume":"22","author":"Lucchelli","year":"1990","journal-title":"Pharmacol Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neulet.2009.08.080","article-title":"Dopamine induces contraction in the proximal, but relaxation in the distal rat isolated small intestine","volume":"465","author":"Kirschstein","year":"2009","journal-title":"Neurosci Lett"},{"key":"B82","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trsl.2012.01.002","article-title":"Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility","volume":"159","author":"Zhang","year":"2012","journal-title":"Transl Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.phrs.2010.01.015","article-title":"D1 receptors play a major role in the dopamine modulation of mouse ileum contractility","volume":"61","author":"Zizzo","year":"2010","journal-title":"Pharmacol Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13105-017-0566-0","article-title":"Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors","volume":"73","author":"Auteri","year":"2016","journal-title":"J Physiol Biochem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"G311","DOI":"10.1152\/ajpgi.2000.279.2.G311","article-title":"Mice lacking the dopamine transporter display altered regulation of distal colonic motility","volume":"279","author":"Walker","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/BF01311254","article-title":"Effects of central and peripheral administration of dopamine on pattern of intestinal motility in dogs","volume":"29","author":"Fioramonti","year":"1984","journal-title":"Dig Dis Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1476-5381.1984.tb16439.x","article-title":"Effects of dopamine and bromocriptine on colonic motility in dog","volume":"82","author":"Bueno","year":"1984","journal-title":"Br J Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF01311668","article-title":"Dopamine-induced migrating myoelectrical complex-like activity in human duodenum","volume":"31","author":"Marzio","year":"1986","journal-title":"Dig Dis Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF01537410","article-title":"Dopamine interrupts gastrointestinal fed motility pattern in humans","volume":"35","author":"Marzio","year":"1990","journal-title":"Dig Dis Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00003643-199904000-00006","article-title":"Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers","volume":"16","author":"Levein","year":"1999","journal-title":"Eur J Anaesthesiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s001340051279","article-title":"Effect of dopamine on gastrointestinal motility during critical illness","volume":"26","author":"Dive","year":"2000","journal-title":"Intensive Care Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice","volume":"26","author":"Li","year":"2006","journal-title":"J Neurosci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T04:13:42Z","timestamp":1571112822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":92,"alternative-id":["10.3389\/fneur.2019.01087"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01087","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"article-number":"1087"}}